FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/11/2025
Voltar para busca
Dado oficial do USPTO
GLX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 42, 45
Data de depósito
21/09/2023
Data de registro
22/04/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/04/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
København N, DK
Examinador
CREEF, DAVIS W
Unidade examinadora
N70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
G. A. (pessoa física)
Representantes
Stacy J. Grossman Law Office of Stacy J. Grossman PLLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Reagents for analytical purposes being reagents for medical purposes; reagents for microbiological analysis being reagents for veterinary purposes; reagents for blood grouping for medical purposes; diagnostic reagents for medical use; biological reagents for medical use; chemical reagents for medical use; diagnostic chemical reagents for medical use; diagnostic biomarker reagents for medical purposes
Classe 9
Downloadable software for use in data management in the medical field; downloadable computer software relating to the medical field for use in data management; software as a medical device (SaMD)downloadablefor diagnosingpredictingprognosticating and monitoring medical conditions; downloadable computer software for use in medical decision support systemsfor diagnosingpredictingprognosticating and monitoring medical conditions; downloadable health monitoring software; downloadable artificial intelligence software for healthcarefor diagnosingpredictingprognosticating and monitoring medical conditions; downloadable machine learning software for healthcarefor diagnosingpredictingprognosticating and monitoring medical conditions; downloadable system and system support softwarefirmware for diagnosingpredictingprognosticating and monitoring medical conditions; downloadable artificial intelligence and machine learning software for diagnosingpredictingprognosticating and monitoring medical conditions; downloadable artificial intelligence software for diagnosingpredictingprognosticating and monitoring medical conditions; downloadable artificial intelligence software for analysis of diagnosingpredictingprognosticating and monitoring medical conditions; downloadable software for making remote medical diagnostics; downloadable machine learning software for diagnosingpredictingprognosticating and monitoring medical conditions; downloadable machine learning software for analysis of medical data
Classe 42
Computer serviceson-site and remote management of information technology (IT) systems of others for the pharmaceutical and healthcare industries; medical and pharmacological research services; software as a service (SaaS) services featuring software platforms using artificial intelligence technology for diagnosingpredictingprognosticating and monitoring medical conditions; DNA sequencing technology research; blood analysis services for scientific research purposes; software as a service (SaaS) featuring software using machine learning technology for diagnosingpredictingprognosticating and monitoring medical conditions; software as a service (SaaS) services featuring software using machine learningdeep learning and deep neural network technology for diagnosingpredictingprognosticating and monitoring medical conditions
Classe 45
Health and safety risk management in the nature of security threat analysis for the protection of individuals; health and safety risk assessment services in the nature of security threat analysis for the protection of individuals; licensing of intellectual property; licensing of industrial property rights; legal services; intellectual property licensing services; licensing of intellectual property in the field of copyrights being legal services; licensing of intellectual property in the field of trademarks being legal services
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/11/2025
FIMP
FINAL DISPOSITION PROCESSED
07/11/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
22/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
22/04/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/04/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/03/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
25/03/2025
PUBO
PUBLISHED FOR OPPOSITION
04/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
10/02/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/02/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
10/02/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/02/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
20/12/2024
GNFR
FINAL REFUSAL E-MAILED
20/12/2024
CNFR
FINAL REFUSAL WRITTEN
20/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/11/2024
RFNT
REFUSAL PROCESSED BY IB
15/07/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/06/2024
RFRR
REFUSAL PROCESSED BY MPU
24/06/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/06/2024
CNRT
NON-FINAL ACTION WRITTEN
17/05/2024
DOCK
ASSIGNED TO EXAMINER
14/05/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/11/2023
MAFR
APPLICATION FILING RECEIPT MAILED
31/10/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/10/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/10/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GLX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.